首页> 外国专利> MEDICINES FOR TREATING TO INCREASED fibrinogen IN PLASMA leading PATHOLOGICAL PROCESSES.

MEDICINES FOR TREATING TO INCREASED fibrinogen IN PLASMA leading PATHOLOGICAL PROCESSES.

机译:治疗血浆中纤维蛋白原增加的药物,可导致病理过程。

摘要

The increase in concentration of one or several plasma-proteins in the blood is specific for various pathological processes, especially inflammations. A medicament which in a typical way, exactly contains increasingly available plasma-proteins for a pathological process, attenuates the progress of the pathological process, as by this means, the defence system of the body itself is strengthened, which reacts in a specific way on such pathological processes, with the increased formation of one or several plasma-proteins specific for this. This effect is especially demonstrated in regard to Fibrinogen. It demonstrates further that the effect of the Fibrinogen is thereupon to be traced back in that, in regard to reaction with Thrombin at the point of the inflammation, the fibrinopeptides A and B are formed.
机译:血液中一种或几种血浆蛋白浓度的增加对各种病理过程(尤其是炎症)具有特异性。以典型方式准确地包含越来越多的血浆蛋白以用于病理过程的药物会减弱病理过程的进程,因为通过这种方式,机体自身的防御系统得到了增强,并在特定的方式下发生反应。这样的病理过程,与此有关的一种或几种血浆蛋白的形成增加。就纤维蛋白原而言,这种效果尤其明显。它进一步证明了纤维蛋白原的作用可以追溯到,因为在炎症时与凝血酶的反应形成了纤维蛋白肽A和B。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号